Membranous nephropathy may be treated with RituximabMembranous nephropathy, a disorder of kidney, can be effectively treated with Rituximab. This finding was disclosed in the April 2009 print issue of the Clinical Journal of the American Society of Nephrology (CJASN).

The effect of rituximab therapy for treating patients struggling against nephropathy was compared by Andrew Bomback, MD (University of North Carolina Kidney Center), and his colleagues after conducting the first systematic review of rituximab use in patients with membranous nephropathy.

Presently, treatment options are limited to calcineurin inhibitors, steroids, and chemotherapeutic agents, all of which have some side effects.

It was remarked by Dr. Bomback that studies in future are required for confirming value of this drug and the use should only be done in research settings till that time.